Compare · ONTO vs TMO
ONTO vs TMO
Side-by-side comparison of Onto Innovation Inc. (ONTO) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ONTO and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $257.53B, about 22.6x ONTO ($11.38B).
- Over the past year, ONTO is up 64.5% and TMO is up 28.0% - ONTO leads by 36.5 points.
- TMO has been more active in the news (7 items in the past 4 weeks vs 4 for ONTO).
- TMO has more recent analyst coverage (25 ratings vs 23 for ONTO).
- Company
- Onto Innovation Inc.
- Thermo Fisher Scientific Inc
- Price
- $220.46-4.90%
- $690.13-0.92%
- Market cap
- $11.38B
- $257.53B
- 1M return
- -11.85%
- +4.77%
- 1Y return
- +64.49%
- +28.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 4
- 7
- Recent ratings
- 23
- 25
Onto Innovation Inc.
Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs macro defect inspection and metrology, lithography systems, and process control analytical software worldwide. It offers process and yield management solutions, and device packaging and test facilities through standalone systems for macro-defect inspection, packaging lithography, probe card test and analysis, and transparent and opaque thin film measurements; and process control software portfolio that includes solutions for standalone tools, groups of tools, or factory-wide suites. The company also provides spare parts and software licensing services. Its products are used by semiconductor wafer and advanced packaging device manufacturers; silicon wafer; light emitting diode; vertical-cavity surface-emitting laser; micro-electromechanical system; CMOS image sensor; power device; RF filter; data storage; and various industrial and scientific applications. The company was formerly known as Rudolph Technologies, Inc. Onto Innovation Inc. was founded in 1940 and is headquartered in Wilmington, Massachusetts.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ONTO
- Onto Innovation Receives Best Partner Award from SK hynix for Hidden Defect Prevention in High Bandwidth Memory Production
- Onto Innovation Opens Registration for December 2026 Analyst Event
- RBC Capital Mkts initiated coverage on Onto Innovation with a new price target
- Director Miller David Brian sold $600,000 worth of shares (2,000 units at $300.00) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 10,692 units (SEC Form 4)
- Chief Financial Officer Roberts Brian K covered exercise/tax liability with 3,239 shares, decreasing direct ownership by 13% to 21,032 units (SEC Form 4) to cover taxes
- Senior Vice President of Custo Chen Shirley covered exercise/tax liability with 1,516 shares, decreasing direct ownership by 10% to 14,001 units (SEC Form 4) to cover taxes
- Amendment: Chief Financial Officer Roberts Brian K covered exercise/tax liability with 3,239 shares, decreasing direct ownership by 13% to 21,032 units (SEC Form 4) to satisfy withholding obligation
- Director Lynch Susan D sold $302,300 worth of shares (1,000 units at $302.30) as part of a pre-agreed trading plan, decreasing direct ownership by 27% to 2,684 units (SEC Form 4)
- Goldman initiated coverage on Onto Innovation with a new price target
- Save the Date: Onto Innovation to Host Analyst Event and Participate in Upcoming Investor Conferences
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)